Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PHAT - Phathom Pharmaceuticals, Inc.
Market Cap 803.81M P/E - EPS this Y -16.80% Ern Qtrly Grth -
Income -201.59M Forward P/E -2.69 EPS next Y 29.40% 50D Avg Chg 8.00%
Sales 682k PEG - EPS past 5Y - 200D Avg Chg 34.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -9.00%
Recommedations 1.90 Quick Ratio 9.88 Shares Outstanding 58.52M 52W Low Chg 144.00%
Insider Own 8.92% ROA -36.14% Shares Float 43.23M Beta 0.63
Inst Own 88.58% ROE - Shares Shorted/Prior 12.03M/10.44M Price 14.25
Gross Margin 75.51% Profit Margin - Avg. Volume 350,793 Target Price 22.71
Oper. Margin -10,245.60% Earnings Date May 8 Volume 908,264 Change -5.63%
Healthcare | Biotechnology | United States
About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Phathom Pharmaceuticals, Inc. News
04/19/24 MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
04/19/24 12 Most Shorted Stocks in 2024
04/05/24 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
04/03/24 Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/26/24 Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
03/08/24 Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript
03/08/24 Q4 2023 Phathom Pharmaceuticals Inc Earnings Call
03/07/24 Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ...
03/07/24 Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/29/24 Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
02/13/24 Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
01/31/24 Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
07:26 AM With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors
12/14/23 Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
12/14/23 Several Insiders Invested In Phathom Pharmaceuticals Flagging Positive News
12/06/23 Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
08:00 AM Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
11/09/23 Phathom Pharmaceuticals Inc (PHAT) Reports Q3 2023 Financial Results
11/09/23 Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
11/01/23 Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
PHAT Chatroom

User Image Hannibal_Smith Posted - 1 day ago

$PHAT How many times a month is Needham going to maintain their price target ? 😅

User Image stocksUP59 Posted - 1 day ago

@sunset_PARK $Phat mentioned on the earnings call that the bulk of Q4 revenues came from retail stocking

User Image DMAY0 Posted - 2 days ago

$PHAT short losers… kick em out of the party.

User Image sunset_PARK Posted - 2 days ago

$PHAT i did this just for fun...very close to Yahoofinance's estimate, though

User Image Sfgiant5 Posted - 2 days ago

$PHAT Shorts are trying harder and harder to keep the price in check.

User Image RonIsWrong Posted - 3 days ago

$PHAT scripts for week ending 4/5 tagging @Biotechster

User Image pfh_investing Posted - 3 days ago

$PHAT getting close to a golden cross on the 200 and 50 MAs btw - something to keep an eye on

User Image pfh_investing Posted - 3 days ago

$PHAT I’m about half the volume so far this morning 😂

User Image pfh_investing Posted - 3 days ago

$PHAT in for another run

User Image Ecryder Posted - 5 days ago

$PHAT glad it’s green day

User Image Biotechster Posted - 5 days ago

$PHAT does anyone have the new rx numbers

User Image StardustTrader Posted - 5 days ago

$PHAT this looks to be the add zone. May take a bite here, avg up a smidgen.

User Image CHRCHR Posted - 5 days ago

$ASLN $PHAT $PYPD $MLEC

User Image teatone Posted - 6 days ago

$PHAT

User Image Stock_Titan Posted - 6 days ago

$PHAT SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT https://www.stocktitan.net/news/PHAT/syn-ox-therapeutics-announces-75m-series-b-round-to-fund-phase-3-agoh7wlhmveo.html

User Image Ecryder Posted - 1 week ago

$PHAT https://www.insidermonkey.com/blog/5-most-shorted-stocks-in-2024-1287311/

User Image stocksUP59 Posted - 1 week ago

$PHAT Bad week

User Image Thestocktraderhubzee Posted - 1 week ago

$PHAT Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

User Image DMAY0 Posted - 1 week ago

$PHAT

User Image DMAY0 Posted - 1 week ago

$PHAT thought biden was going to cure cancer… he cant even cure GERD!!! another red day 😵‍💫

User Image ScottyDoesntKnowMeSon Posted - 1 week ago

$PHAT add time

User Image sunset_PARK Posted - 1 week ago

$PHAT any weekly scripts update?

User Image Ecryder Posted - 1 week ago

$PHAT let’s bounce already!

User Image DMAY0 Posted - 1 week ago

$PHAT FFS! come on!!!

User Image CH_Expat Posted - 1 week ago

$PHAT Added at 9.59 USD.

User Image Zzzquil Posted - 1 week ago

$PHAT averaging up here

User Image Creamcheeze Posted - 1 week ago

$PHAT It takes years for drugs to get market share. In Japan, over 8 years to reach its pinnacle. Unsure if we can do that faster, cheaper, and more efficiently in this country...

User Image CHCInvestments Posted - 1 week ago

$PHAT This one has my total attention. Sure wish I could get a low $9 load up chance. Been trying to sell puts and back into shares.......but not a lot of option action. $GRRR Is another one I have on high alert. I expect this thing to just rip at some point. Fresh reverse split, low float.......AI play. $RITM is my top MREIT play. This company is a hybrid REIT in my opinion. Has it's hands in a lot of cookie jars, from home rentals to MSR's to mortgage companies and hedge funds. $13-16+ one of these days in near future (may take up to a year or so to reach full potential). I am about to get bullish on $SPY and $SPX options.....I may be early, but I think we see a nice bounce in next 5 trading days. Sold SPX Iron Condor today that expires tomorrow......see how this plays out. Enough rambling from me. Peace out!

User Image DMAY0 Posted - 1 week ago

$PHAT we did better without all these new random posters……

User Image Garrobo Posted - 1 week ago

$PHAT https://www.youtube.com/watch?v=D3RLca_-vuA

Analyst Ratings
Needham Buy Apr 26, 24
Needham Buy Apr 19, 24
Needham Buy Apr 12, 24
Needham Buy Apr 11, 24
Needham Buy Apr 5, 24
Needham Buy Apr 1, 24
Needham Buy Mar 22, 24
Needham Buy Mar 15, 24
Needham Buy Mar 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jan 24 Sell 8.10 3,703,703 29,999,994 3,755,583 01/25/24
Henderson Molly CFO and CBO CFO and CBO Jan 18 Sell 7.7533 6,307 48,900 98,698 01/22/24
Parikh Asit Director Director Nov 06 Buy 7.87 7,500 59,025 55,000 11/08/23
Henderson Molly CFO and CBO CFO and CBO Jun 02 Sell 11.4121 1,960 22,368 68,506 06/05/23
Henderson Molly CFO and CBO CFO and CBO May 22 Sell 12.8744 2,110 27,165 70,466 05/23/23
Curran Terrie President and Chief.. President and Chief Executive Mar 01 Sell 8.5411 1,436 12,265 175,371 03/03/23
Curran Terrie President and Chief.. President and Chief Executive Jan 19 Sell 8.2 5,821 47,732 176,807 01/20/23
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer May 16 Buy 8.1644 20,000 163,288 785,700 05/16/22
Curran Terrie President and Chief.. President and Chief Executive May 13 Buy 7.4066 20,500 151,835 64,595 05/16/22
Parikh Asit Director Director May 12 Buy 8.00 12,500 100,000 12,500 05/16/22
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Mar 14 Sell 19 18 342 7,459,286 03/16/22
COLA MICHAEL F Director Director Oct 29 Buy 19.00 9,798 186,162 9,798 02/18/22
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Nov 04 Sell 19.93 1,000,001 19,930,020 100,000 11/08/21
Socks David A Director Director Oct 07 Sell 32.36 18,000 582,480 1,211,346 10/08/21
Socks David A Director Director Aug 18 Sell 30.98 18,000 557,640 1,247,346 08/18/21
Socks David A Director Director Jun 29 Sell 34.39 40,000 1,375,600 1,260,945 06/29/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 29 Sell 35.54 24,501 870,766 882,240 06/29/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 25 Sell 35.07 11,048 387,453 906,741 06/25/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 23 Sell 35.16 9,394 330,293 917,789 06/23/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 11 Sell 35.21 3,293 115,947 938,712 06/11/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 09 Sell 35.03 2,364 82,811 942,005 06/09/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 02 Sell 36.21 20,116 728,400 948,669 06/02/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 28 Sell 36.98 20,811 769,591 968,785 05/28/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 26 Sell 36.11 21,541 777,846 989,596 05/26/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 24 Sell 35.42 18,746 663,983 1,011,137 05/24/21
Socks David A Director Director May 21 Sell 33.68 40,000 1,347,200 1,300,945 05/21/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 14 Sell 35.59 11,876 422,667 1,029,983 05/14/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 07 Sell 35.08 7,138 250,401 1,042,870 05/07/21
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Apr 05 Sell 36.91 14,500 535,195 780,200 04/05/21
Curran Terrie President and Chief.. President and Chief Executive Mar 23 Option 6.95 11,513 80,015 11,513 03/23/21
Curran Terrie President and Chief.. President and Chief Executive Mar 23 Sell 43.66 11,513 502,658 03/23/21
Socks David A Director Director Jan 13 Sell 35.62 40,000 1,424,800 1,532,945 01/13/21
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Jan 05 Sell 33.82 14,500 490,390 823,700 01/05/21
Socks David A Director Director Dec 18 Sell 44.95 79,658 3,580,627 1,572,945 12/18/20
Socks David A Director Director Nov 12 Sell 41.45 30,342 1,257,676 1,652,603 11/12/20
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Nov 03 Sell 36.83 14,500 534,035 852,700 11/03/20